Literature DB >> 2412780

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

E M Sorkin, S P Clissold, R N Brogden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412780     DOI: 10.2165/00003495-198530030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  499 in total

1.  Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

Authors:  D P Zipes; J C Fischer
Journal:  Circ Res       Date:  1974-02       Impact factor: 17.367

2.  Nifedipine for Raynaud's phenomenon.

Authors: 
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

3.  Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failure.

Authors:  I Cantelli; P C Pavesi; C Parchi; F Naccarella; D Bracchetti
Journal:  Am Heart J       Date:  1983-08       Impact factor: 4.749

4.  Nifedipine, a new antihypertensive with rapid action.

Authors:  M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

5.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

Review 6.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

7.  Nifedipine plasma concentration in patients treated for angina pectoris.

Authors:  Z Stern; E Zylber-Katz; M Levy
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-04

8.  Modification of left ventricular response to pacing tachycardia in nifedipine in patients with coronary artery disease.

Authors:  B H Lorell; Z Turi; W Grossman
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

9.  Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.

Authors:  C de Ponti; F Mauri; G R Ciliberto; B Carù
Journal:  Eur J Cardiol       Date:  1979-07

10.  Nifedipine in unstable angina: a double-blind, randomized trial.

Authors:  G Gerstenblith; P Ouyang; S C Achuff; B H Bulkley; L C Becker; E D Mellits; K L Baughman; J L Weiss; J T Flaherty; C H Kallman; M Llewellyn; M L Weisfeldt
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

View more
  92 in total

1.  Cortical blindness after nifedipine treatment.

Authors:  C Morton; M Hickey-Dwyer
Journal:  BMJ       Date:  1992-09-19

2.  Pharmacokinetics of nifedipine derived from a new retard tablet formulation.

Authors:  A Avgerinos; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

3.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

4.  An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.

Authors:  T Edeki; A Johnston; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  Raynaud's syndrome.

Authors:  E D Cooke; A N Nicolaides
Journal:  BMJ       Date:  1990-03-03

6.  Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors:  Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

Review 7.  Pharmacokinetics of tocolytic agents.

Authors:  Vassilis Tsatsaris; Dominique Cabrol; Bruno Carbonne
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Effect of nifedipine on anorectal sensorimotor functions in health and fecal incontinence.

Authors:  Adil E Bharucha; Jessica Edge; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-14       Impact factor: 4.052

Review 9.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

Review 10.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.